EpiX Analytics is pleased to announce that Dr. Francisco J. Zagmutt has assumed full ownership of the company. Dr. Huybert Groenendaal will be moving on to new endeavors, and we wish him every success in his next chapter.
We want to reassure our clients, collaborators, and partners that EpiX’s business model, services, and commitment to rigorous analytics remain unchanged.
Dr. Zagmutt shared the following message: “I am excited to continue leading the company with the same dedication, vision, and obsessive quality that have always been at the heart of EpiX. This change will allow us to have a renewed focus on our core expertise in state-of-the-art analytics and risk modeling to improve decisions under uncertainty.”
We sincerely thank our clients and partners for their continued trust and support. The EpiX team looks forward to building on our strong foundation and continuing to deliver excellence together.
New Article! Incorporating genomic virulence in a quantitative microbial risk assessment to assess the public health impact of alternative microbiological criteria for Salmonella